Knight-Swift (KNX) upgraded to Buy: freight cycle trough passes, pricing stabilizes, and cost resets boost margins.

Abbott Laboratories fell on its latest earnings report, but I view this as a buying opportunity. Read the latest analysis on ...

DeskIn attempts to challenge that divide that instead of forcing users to choose between productivity and performance, it is ...